- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Thomas J. Spulak
Events 28 results
Conference
March 17, 2025
34th Annual King & Spalding Health Law & Policy Forum
Speaking Engagement
January 30, 2025
Thomas Spulak, Cal Smith, and Peter Wozniak to Speak at the National Associate of Corporate Directors
Speaking Engagement
December 6, 2024
Tom Spulak to Speak at the FARA Conference
Conference
September 30, 2024
Annual Health Law & Policy Forum West
Speaking Engagement
June 4, 2024
K&S Panelists to Speak at Denmark/U.S. Defense Industry Conference
Speaking Engagement
February 15, 2024
Tom Spulak to Speak at Florida State Guardianship Association
Webinar
October 26, 2023
Navigating the Foreign Agents Registration Act (FARA): Where is DOJ Headed?
Conference
March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
Conference
March 8, 2023
California Life Sciences Summit
Webinar
January 19, 2023
A New Year, A New Day - What’s Next for Healthcare Policy and Oversight in the New Congress
Conference
November 1, 2022
Pharmaceutical University 2022
Conference
April 27, 2017
Quarterly Energy Forum